Molina Healthcare (NYSE:MOH) Director Sells $159,481.08 in Stock

Molina Healthcare, Inc (NYSE:MOH – Get Free Report) Director Richard Schapiro sold 782 shares of the stock in a transaction that occurred on Tuesday, November 10th. The shares were sold at an average price of $203.94, for a total value of $159,481.08. Following the completion of the sale, the director directly owned 11,833 shares of the company’s stock, valued at $2,413,222.02. This represents a 6.20% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Molina Healthcare Trading Down 0.1%

Shares of MOH stock opened at $209.37 on Monday. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.95. Molina Healthcare, Inc has a 1 year low of $121.06 and a 1 year high of $244.89. The firm’s fifty day simple moving average is $202.56 and its 200 day simple moving average is $185.69. The firm has a market capitalization of $10.93 billion, a P/E ratio of -218.09, a price-to-earnings-growth ratio of 12.35 and a beta of 0.74.

Molina Healthcare (NYSE:MOH – Get Free Report) last posted its quarterly earnings data on Wednesday, October 21st. The company reported $0.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.79 by $0.10. Molina Healthcare had a negative net margin of 0.11% and a positive return on equity of 2.50%. The company had revenue of $11.08 billion for the quarter, compared to the consensus estimate of $10.86 billion. During the same quarter in the previous year, the firm posted $1.84 EPS. The business’s revenue was down 3.4% compared to the same quarter last year. As a group, sell-side analysts predict that Molina Healthcare, Inc will post 5.30 EPS for the current year.

Key Molina Healthcare News

Here’s some of the latest news about MOH:

  • Negative Sentiment: Zacks Research lowered its EPS estimates for Q1 2027 to $2.48 from $2.53, Q3 2027 to $2.17 from $2.23, and Q3 2028 to $3.85 from $4.06. The analyst firm maintained a Hold rating; the downward revisions may weigh on sentiment about Molina’s earnings outlook.
  • Negative Sentiment: Three insiders reported selling a combined 10,382 shares for about $2.11 million, reducing their individual holdings by roughly 6% to 12%. These sales may be viewed as a negative signal, though insider transactions alone do not establish a change in the company’s fundamentals. Jeff Barlow SEC filing Richard Schapiro SEC filing Dale Wolf SEC filing

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. Jefferies Financial Group restated a “hold” rating and set a $220.00 price objective on shares of Molina Healthcare in a research report on Friday, October 23rd. Sanford C. Bernstein reissued an “outperform” rating on shares of Molina Healthcare in a research note on Tuesday, October 27th. Barclays decreased their price objective on Molina Healthcare from $180.00 to $178.00 and set an “underweight” rating on the stock in a report on Friday, October 23rd. Mizuho set a $255.00 target price on Molina Healthcare in a research report on Friday, October 23rd. Finally, Truist Financial lowered their price target on Molina Healthcare from $250.00 to $225.00 and set a “hold” rating on the stock in a research report on Friday, July 24th. Three analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $213.88.

Read Our Latest Stock Analysis on MOH

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of MOH. Fortitude Family Office LLC boosted its stake in Molina Healthcare by 63.7% in the third quarter. Fortitude Family Office LLC now owns 131 shares of the company’s stock worth $25,000 after purchasing an additional 51 shares in the last quarter. Elevation Wealth Partners LLC grew its holdings in Molina Healthcare by 118.2% during the 2nd quarter. Elevation Wealth Partners LLC now owns 144 shares of the company’s stock worth $33,000 after acquiring an additional 78 shares during the last quarter. Global Retirement Partners LLC bought a new position in shares of Molina Healthcare in the second quarter worth about $39,000. Versant Capital Management Inc lifted its position in shares of Molina Healthcare by 341.6% during the second quarter. Versant Capital Management Inc now owns 340 shares of the company’s stock worth $78,000 after purchasing an additional 263 shares in the last quarter. Finally, Contravisory Investment Management Inc. bought a new stake in shares of Molina Healthcare during the second quarter valued at approximately $89,000. Institutional investors own 98.50% of the company’s stock.

Molina Healthcare Company Profile

(Get Free Report)

Molina Healthcare, Inc. is a managed care company that provides health insurance plans primarily to people covered by government-sponsored programs. Its offerings include Medicaid plans, Medicare plans for eligible individuals and dual-eligible members, and health plans sold through government marketplaces under the Affordable Care Act. The company was founded in 1980 by physician C. David Molina in Long Beach, California, initially serving low-income families through community clinics. It later shifted its focus to providing managed health care, with Medicaid becoming a central part of its business.

Recommended Stories

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.